Table 2.

Antimicrobial susceptibility profiles of carbapenem-non-susceptible Enterobacteriaceae

			Antimicrobial agent and MIC(µg/mL)
Isolatea	MH Tb	Genoty pe	Ertapenem	Imipenem	Gentamicin	Tobramycin	Piperacillin/tazobactam	Ceftriaxone	Ceftazidime	Cefepime	Ciprofloxacin	Trimethoprim/sulfamethoxazole
KPN1	+	blaIMP-4	4	8	≤1	≤1	8	≥64	≥64	32	≤0.25	≥320
KPN2	+	blaIMP-4	≥8	2	≥16	8	64	≥64	≥64	≥64	2	≥320
KPN3	+	blaIMP-4	4	≤1	≥16	8	8	≥64	≥64	≥64	1	≥320
KPN4	−	None	4	2	≥16	8	8	≥64	≥64	32	1	≥320
KPN5	+	blaIMP-4	4	≤1	≥16	8	8	≥64	≥64	8	0.5	≥320
KPN6	+	None	4	8	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN7	+	blaIMP-4	≥8	≤1	≥16	8	64	≥64	≥64	16	2	≥320
KPN8	+	blaIMP-4	4	≤1	≥16	8	32	≥64	≥64	≥64	2	≥320
KPN9	+	None	4	≤1	≥16	8	16	≥64	≥64	≥64	2	≥320
KPN1 0	+	blaIMP-4	≥8	≤1	≥16	8	8	≥64	≥64	8	1	≥320
KPN1 1	+	blaIMP-4	4	≤1	≥16	8	8	≥64	≥64	8	2	≥320
KPN1 2	+	blaIMP-4	4	2	≥16	8	8	≥64	≥64	≥64	2	≥320
KPN1 3	+	None	4	≤1	≥16	8	8	≥64	≥64	8	1	≥320
KPN1 4	+	blaIMP-8	4	≤1	≥16	8	≥128	≥64	≥64	≥64	1	≥320
KPN1 5	+	blaIMP-8	4	4	2	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN1 6	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN1 7	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN1 8	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN1 9	+	blaIMP-8	4	2	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN2 0	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN2 1	+	blaIMP-8	4	8	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN2 2	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN2 3	+	blaIMP-8	4	4	4	8	8	≥64	≥64	≥64	≤0.25	≥320
KPN2 4	+	blaIMP-8	4	2	≤1	8	8	≥64	≥64	16	≤0.25	≥320
ECL1	−	None	4	≤1	≥16	≥16	≥128	≥64	≥64	≥64	≥4	≥320
ECL2	−	None	4	≤1	≥16	≥16	≥128	≥64	≥64	≥64	≥4	≤20
ECL3	−	None	4	≤1	≥16	≥16	≥128	≥64	≥64	≥64	0.5	≤20
ECL4	+	blaIMP-8	≥8	4	≤1	≤1	8	≥64	≥64	32	≤0.25	≥320
KOX 1	−	blaIMP-4	≥8	8	≥16	≥16	≥128	≥64	≥64	≥64	≥4	80
KOX 2	+	blaIMP-4	≥8	≥16	≥16	≥16	≥128	≥64	≥64	≥64	≥4	≥320